Insmed Inc (INSM)vsPureTech Health PLC (PRTC)
INSM
Insmed Inc
$148.31
+6.59%
HEALTHCARE · Cap: $29.99B
PRTC
PureTech Health PLC
$15.91
+1.11%
HEALTHCARE · Cap: $383.51M
Smart Verdict
WallStSmart Research — data-driven comparison
Insmed Inc generates 9389% more annual revenue ($606.42M vs $6.39M). PRTC leads profitability with a 7.9% profit margin vs -2.1%. PRTC earns a higher WallStSmart Score of 51/100 (C-).
INSM
Hold39
out of 100
Grade: F
PRTC
Buy51
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for INSM.
Margin of Safety
+78.0%
Fair Value
$79.56
Current Price
$15.91
$63.65 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
Attractively priced relative to earnings
Earnings expanding 61.5% YoY
Areas to Watch
1.5% revenue growth
0.0% earnings growth
Trading at 43.0x book value
ROE of -2.5% — below average capital efficiency
Trading at 10.1x book value
Smaller company, higher risk/reward
7.9% margin — thin
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : INSM
PEG of 1.09 suggests the stock is reasonably priced for its growth.
Bull Case : PRTC
The strongest argument for PRTC centers on P/E Ratio, EPS Growth.
Bear Case : INSM
The primary concerns for INSM are Revenue Growth, EPS Growth, Price/Book.
Bear Case : PRTC
The primary concerns for PRTC are Price/Book, Market Cap, Profit Margin.
Key Dynamics to Monitor
INSM profiles as a turnaround stock while PRTC is a value play — different risk/reward profiles.
INSM carries more volatility with a beta of 1.17 — expect wider price swings.
PRTC is growing revenue faster at 5.4% — sustainability is the question.
PRTC generates stronger free cash flow (-46M), providing more financial flexibility.
Bottom Line
PRTC scores higher overall (51/100 vs 39/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Insmed Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.
PureTech Health PLC
HEALTHCARE · BIOTECHNOLOGY · USA
PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops and markets drugs for inflammatory, fibrotic and immune, intractable, lymphatic and gastrointestinal, neurological and neuropsychological cancers and other diseases in the United States. The company is headquartered in Boston, Massachusetts.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?